SCHEMBL12373379

SCHEMBL12373379

COC(=O)CCN(CCC[Si](O)(O)O)CCC(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 4/20 0.45
LMNA P02545 3/20 0.38
ALDH1A1 P00352 3/20 0.38
RECQL P46063 1/20 0.37
KDM5A P29375 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
CA12 O43570 2/20 0.33
CA14 Q9ULX7 2/20 0.33
GLA P06280 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HSD17B10 Q99714 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPRT1 P00492 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15358873 0.87 KMT2A (0.46) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055301 0.84 KMT2A (0.58) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055296 0.84 KMT2A (0.58) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055302 0.84 KMT2A (0.58) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL29527615 0.84 KMT2A (0.46) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL3978909 0.84 KMT2A (0.46) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055298 0.82 KMT2A (0.56) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055304 0.82 KMT2A (0.56) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL2055297 0.82 KMT2A (0.56) KMT2AMEN1TSHRLMNAALDH1A1
SCHEMBL12450195 0.82 KMT2A (0.56) KMT2AMEN1TSHRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321031-B2 Magnetic-cored dendrimer, the method for preparing the same, and the contaminant treatment method using the same IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2016-04-26 US disclosed
US-20130289292-A1 MAGNETIC-CORED DENDRIMER, THE METHOD FOR PREPARING THE SAME, AND THE CONTAMINANT TREATMENT METHOD USING THE SAME IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2013-10-31 US disclosed
US-20110192800-A1 MAGNETIC-CORED DENDRIMER, THE METHOD FOR PREPARING THE SAME, AND THE CONTAMINANT TREATMENT METHOD USING THE SAME IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110192800-A1 MAGNETIC-CORED DENDRIMER, THE METHOD FOR PREPARING THE SAME, AND THE CONTAMINANT TREATMENT METHOD USING THE SAME FLOT1, HAMP, DNM1 KMT2A 252/4885MEN1 60/4885TSHR 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.